Nephrology

A plant-based dietary pattern was associated with lower all-cause and renal-related mortality in patients with chronic kidney disease.

Finerenone significantly slowed kidney function decline and reduced cardiovascular-kidney risk in patients with non-diabetic CKD in the FIND-CKD trial.

New ERA Congress research suggests DCCBs may be linked to worse kidney outcomes in patients with Type 2 diabetes despite standard therapies.

Exploratory findings suggest that organ protection is promoted through calorie restriction in living kidney donors.

New FLOW trial data show semaglutide improves health-related quality of life in people with Type 2 diabetes and chronic kidney disease.

A cross-section study from Romania found that sarcopenia and obesity work additively rather that synergistically to increase mortality risk in older adults with chronic kidney disease.

Researchers discovered that red blood cells mirror endothelial glycocalyx damage, paving the way for blood-based liquid biopsies of vascular health.

Early-onset kidney stone disease was linked to higher rates of metabolic and cardiovascular comorbidities in a cohort study of 546 patients.